Fungal Infections in Liver Transplant Recipients!
نویسنده
چکیده
Sixty-two adults who underwent orthotopic liver transplantations between February 1981 and June 1983 were followed for a mean of 170 days after the operation. Twenty-six patients developed 30 episodes of significant fungal infection. Candida species and Torulopsis glabrata were responsible for 22 episodes and Aspergillus species for 6. Most fungal infections occurred in the first month after transplantation. In the first 8 wee)ts after transplantation, death occurred in 69% (18/26) of patients with fungal infection but in only 8% (3/36) of patients without fungal infection (P<0.0005). The cause of death, however, was usually multifactorial, and not solely due to the fungal infection. Fungal infections were associated with the following clinical factors: administration of preoperative steroids (P<0.05) and antibiotics (P<0.05), longer transplant operative time (P<0.02), longer posttransplant operative time (P<O.Ol), duration of antibiotic use after transplant surgery (P<O.OOl), and the number of steroid boluses administered to control rejection in the first 2 posttransplant months (P<O.Ol). Patients with primary biliary cirrhosis had fewer fungal infections than patients with other underlying liver diseases (P<O.05). A total of 41 % (9/22) of Candida infections resolved, but all Aspergillus infections ended in death.
منابع مشابه
Fungal Infections After Liver Transplantation.
A STUDY DONE at our institution between 1981 and 1983 showed that 42% of liver recipients developed invasive fungal infections, mostly due to Candida and Aspergillus. l Between July 1984 and September 1985 we studied 101 consecutive adult liver transplant recipients at Presbyterian University Hospital for the incidence and risk factors associated with invasive fungal infection. The risk factors...
متن کاملEpidemiology of fungal infections in liver transplant recipients: a six-year study of a large Brazilian liver transplantation centre.
Liver transplant seems to be an effective option to prolong survival in patients with end-stage liver disease, although it still can be followed by serious complications. Invasive fungal infections (ifi) are related to high rates of morbidity and mortality. The epidemiology of fungal infections in Brazilian liver transplant recipients is unknown. The aim of this observational and retrospective ...
متن کاملFungal infections in solid-organ transplantation.
Fungal infections following solid-organ transplantation remain a major cause of morbidity and death. Their incidence ranges from 5% among recipients of kidney transplants to as high as 40% among recipients of liver transplants. Species of Candida and Aspergillus account for more than 80% of fungal episodes. Moreover, more than 80% of fungal infections occur within the first 2 months after trans...
متن کاملInvasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent.
Invasive fungal infections and their risk factors were prospectively assessed in 130 consecutive liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Eleven percent (14) of the 130 patients had 17 episodes of invasive fungal infections. These included candidiasis (5%; 6 patients), cryptococcosis (5%; 6), aspergillosis (3%; 4), and chromomycosis (1%; 1). An el...
متن کاملRandomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
Invasive fungal infections (IFIs) are a common complication in liver transplant recipients. There are no previous randomized trials of an echinocandin for the prevention of IFIs in solid organ transplant recipients. In a randomized, double-blind trial conducted at University-affiliated transplant centers, 200 high-risk liver transplant recipients (100 patients per group) received either anidula...
متن کاملAntifungal Prophylaxis in Liver Transplant Recipients.
Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no consensus exists on which patients should receive prophylaxis, with which agent, and for what duration...
متن کامل